Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_4
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 42 (66.7%)
N/A1 (33.3%)

Trials by Status

withdrawn133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnphase_4

Tetrandrine Tablets Used in Hospitalized Adults With COVID-19

NCT05697029
unknownnot_applicable

Tetrandrine in the Treatment of Rheumatoid Arthritis

NCT05245448
unknownphase_4

Tetrandrine Tablets Used in the Treatment of COVID-19

NCT04308317

Clinical Trials (3)

Showing 3 of 3 trials
NCT05697029Phase 4

Tetrandrine Tablets Used in Hospitalized Adults With COVID-19

Withdrawn
NCT05245448Not Applicable

Tetrandrine in the Treatment of Rheumatoid Arthritis

Unknown
NCT04308317Phase 4

Tetrandrine Tablets Used in the Treatment of COVID-19

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3